Potential Role of Cannabinoid Type 2 Receptors in Neuropsychiatric and Neurodegenerative Disorders.

Ishiguro, Hiroki; Kibret, Berhanu Geresu; Horiuchi, Yasue; Onaivi, Emmanuel S

Ishiguro, Hiroki; Kibret, Berhanu Geresu; Horiuchi, Yasue; Onaivi, Emmanuel S.

Afiliación

Ishiguro H; Department of Clinical Genetics, Graduate School of Medical Science, University of Yamanashi, Kofu, Japan.
Kibret BG; Department of Neuropsychiatry, Graduate School of Medical Science, University of Yamanashi, Kofu, Japan.
Horiuchi Y; Department of Biology, College of Science and Health, William Paterson University, Wayne, NJ, United States.
Onaivi ES; Department of Psychiatry and Behavioral Sciences, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.

Front Psychiatry ; 13: 828895, 2022.

Article en En | MEDLINE | ID: mdl-35774086

Palabras clave

cannabinoid CB2 receptors; neurodegenerative (ND) disorders; neuronal and glia activation; neuropsychiatric disorders

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Psychiatry Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google